Radiat Oncol J.  2016 Jun;34(2):156-159. 10.3857/roj.2016.01732.

Delayed radiation-induced inflammation accompanying a marked carbohydrate antigen 19-9 elevation in a patient with resected pancreatic cancer

Affiliations
  • 1Department of Radiation Oncology, West Virginia University School of Medicine, Morgantown, WV, USA. malcolm.mattes@gmail.com
  • 2Department of Surgery, West Virginia University School of Medicine, Morgantown, WV, USA.

Abstract

Although carbohydrate antigen (CA) 19-9 is a useful tumor marker for pancreatic cancer, it can also become elevated from a variety of benign and malignant conditions. Herein we describe an unusual presentation of elevated CA 19-9 in an asymptomatic patient who had previously undergone adjuvant chemotherapy and radiation therapy for resected early stage pancreatic cancer. The rise in CA 19-9 might be due to delayed radiation-induced inflammation related to previous intra-abdominal radiation therapy with or without radiation recall induced by gemcitabine. After treatment with corticosteroids the CA 19-9 level decreased to normal, and the patient has not developed any evidence of recurrent cancer to date.

Keyword

Pancreatic cancer; Biologic tumor marker; Radiation therapy; Radiation recall reaction; CA 19-9 antigen

MeSH Terms

Adrenal Cortex Hormones
Biomarkers, Tumor
CA-19-9 Antigen
Chemotherapy, Adjuvant
Humans
Inflammation*
Pancreatic Neoplasms*
Radiodermatitis
Adrenal Cortex Hormones
Biomarkers, Tumor
CA-19-9 Antigen
Full Text Links
  • ROJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr